Blog

In a recent op-ed for Bloomberg Law, C4IP Board Members and retired Federal Circuit Judges Paul Michel and Kathleen O’Malley argue that Congress must pass the bipartisan Patent Eligibility Restoration Act in order to repair the damage the Supreme Court has inflicted on America’s innovation ecosystem. For more than a decade, a series of rulings

This month, C4IP is honoring John B. Goodenough (1922-2023), whose work on the invention of the lithium-ion battery powers billions of high-tech devices and is reshaping renewable energy. Born in Germany and raised in Connecticut, Goodenough earned his Ph.D. in physics from the University of Chicago after serving in World War II and went on

This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the U.S. patent system by deciding that certain categories of innovation should not receive patents by widening the “judicial exceptions” to what is eligible to be patented under 35 U.S.C. § 101. Starting in

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a crucial role in promoting innovation — both in the drug industry and in other sectors — lawmakers and activists cite these myths as evidence of the need for legislation that would limit or

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From entertainment to housework, every aspect of our lives has benefited greatly from IP, as shown by these historical examples from the month of August: 1960: On August 23, Peter Goldmark received a patent for

August Highlights: Setting the Record Straight on the DOJ/FTC Listening Sessions The Department of Justice and Federal Trade Commission recently hosted listening sessions on “Lowering Americans’ Drug Prices Through Competition.” While aimed at exploring ways to expand generic and biosimilar availability, the sessions amplified misleading claims about the patent system — such as allegations of

In a new piece for Newsweek, Mircea Geoană, former NATO deputy secretary general and president of the Aspen Institute Romania, and Andrei Iancu, C4IP co-chair and former USPTO Director, warn that protecting intellectual property (IP) is not merely a trade issue, but a national security imperative. Strong and enforceable IP rights give innovators the confidence

In a piece published by Newsweek, C4IP Board Member and former U.S. Ambassador to China Gary Locke explains how, even as Chinese companies debut world-class technologies — like BYD’s lightning-quick EV charger and DeepSeek’s powerful AI model — some Chinese businesses and leaders are undermining the international agreements that underpin global innovation. Locke points to

In a new Law360 op-ed, C4IP Board Member and former Federal Judge Kathleen O’Malley explains why Congress should advance bipartisan reforms that would strengthen America’s patent system and protect innovation. She points to three bills as critical starting points. The Patent Eligibility Restoration Act would restore clarity for patent eligibility in emerging high-tech fields like

In recent months, federal policymakers have renewed calls for “Most-Favored-Nation” (MFN) drug pricing, which would tie the price of medicines in the United States to the lowest prices paid in similarly wealthy foreign countries. The policy is well-meaning and directed at a real problem: foreign countries free-ride off of American-supported innovation by implementing policies that

C4IP is honoring Charles W. Hull (born 1939), who has transformed manufacturing, medicine, and design through his invention of stereolithography — better known as 3D printing. Hull was born in Clifton, Colorado, and studied engineering physics at the University of Colorado before joining Ultraviolet Products, a company that used UV light to solidify liquid plastic

July Highlights: Congress Rejects Big Tech’s Push to Block AI Rules During last month’s deliberations on the One Big Beautiful Bill Act (OBBBA), Big Tech lobbyists pushed to include an “AI moratorium” provision that would have imposed a 10-year ban on state-level regulation of artificial intelligence. While the proposal was framed as a well-intentioned effort